Results

Total Results: 1,073 records

Showing results for "disease".

121. Strategies to Better Manage Lipids – Statin Pearls
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/strategies-to-better-manage-lipids.pptx
     November 01, 2016 - High risk is defined as: Having a diagnosis of atherosclerotic cardiovascular disease Ever having an … 10-year CVD event risk of ≥10% The USPSTF recommends that adults without a history of cardiovascular disease … (CVD) (i.e., symptomatic coronary artery disease or thrombotic stroke) use a low- to moderate-dose statin … CVD event risk of less than 10%, the likelihood of benefit is smaller due to a lower probability of disease

122. Graphics for Section 7C. Socioeconomic Status (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-c.pdf
     November 26, 2013 -                                                                               Q‐METRIC Sickle Cell Disease … Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for

123. Graphics for Section 7D, Rurality/Urbanicity (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-graphics-section-7-d.pdf
     November 26, 2013 -                                                       Q‐METRIC Sickle Cell Disease … Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Graphics for

124. EvidenceNow Executive Summary - New York City Cooperative (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-nyc.pdf
     November 01, 2017 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … the most diverse (29 percent Hispanic, 25.5 percent African American, and 13 percent Asian).1 Heart disease … is the primary cause of death in the city, and prevalence of cardiovascular disease (CVD) risk factors … .2 Residents of the poorest neighborhoods consistently have higher mortality rates from almost all diseases … • Using Practice Facilitation in primary care settings to reduce risk factors for cardiovascular disease

125. EvidenceNOW: New York City Cooperative | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/nyc.html
     March 01, 2021 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … the most diverse (29 percent Hispanic, 25.5 percent African American, and 13 percent Asian). 1 Heart disease … is the primary cause of death in the city, and prevalence of cardiovascular disease (CVD) risk factors … 2 Residents of the poorest neighborhoods consistently have higher mortality rates from almost all diseases … Facilitation in a Cluster Randomized Stepped Wedge Design Trial to Improve Adherence to Cardiovascular Disease

126. Building Investigative Practices for Better Health Outcomes Research Network | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/ncepcr/communities/pbrn/registry/building-investigative-practices-better-health-outcomes-research-network.html
     January 01, 2012 - Current or Past Research Interests / Health Conditions: Behavioral health Cardiovascular disease … including stroke and HTN* Chronic pain Dementia, including Alzheimer's disease (brain and nerve … conditions)* Diabetes (Type 1 or 2)* Obesity* Other health or disease related interests Pulmonary … disease/asthma* Current or Past Research Interests Comments : Other: Health risk assessment

127. CHIPRA 194: Section 1, Tables 6-10 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-1-tables-6-10.pdf
     April 17, 2019 - 013.0 Meningococcal meningitis 036.0 HIV 042 Meningitis due to enterovirus 047 Other enterovirus diseases … of the central nervous system 048 Other non-arthropod-borne viral diseases of central nervous system … Neurofibromatosis 237.7x Personal history of malignant neoplasm of – brain V10.85 Sickle cell disease … specified hemorrhagic conditions 287.8 Unspecified hemorrhage conditions 287.9 Other specific diseases … Surgery to heart and great vessels V15.1 Table 10 [=IMG8]: ICD-9-CM Codes to Identify Vascular Disease

128. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
     February 12, 2018 - percentile for age in the absence of external vagal stimulus, β-blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

129. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
     February 09, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven

130. Section 1, Tables 1 and 2 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
     April 26, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

131. 3P_RD_AHRQ_PUF_Data_Dictionary (xls file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/data/3P-RD-Data-Dictionary.xlsx
     March 16, 2023 - secondary specialty in the CORE file Medical specialties include: Allergy/Immunology; Cardiovascular Disease … ; Nephrology; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology … Medical specialties include: Allergy/Immunology; Cardiovascular Disease (Cardiology); Interventional … Cardiology; Dermatology; Gastroenterology; Neurology; Cardiac Electrophysiology; Pulmonary Disease; Nephrology … ; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology/Oncology

132. Step 5: Decide on a Treatment Plan | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/questions/resources/diagnosis/step5.html
     November 01, 2020 - —Bob, person with a neurological disorder At this point, you have learned about your disease or condition … This plan will include everything that will be done to treat or manage your disease or condition—including

133. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/policymakers/chipra/overview/background/references.html
     December 01, 2009 - Centers for Disease Control and Prevention. … Diseases Immunization Services Division Assessment Branch; 2009. 31. … Centers for Disease Control and Prevention. … Summary of Notifiable Diseases—United States, 2007--TABLE 3. … Reported cases and incidence* of notifiable diseases, by age group—United States, 2007.

134. Clinical Recommendation: Statins in Primary Prevention of CVD | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/evidencenow/heart-health/cholesterol/uspstf.html
     September 01, 2018 - Prevention of CVD Resource title: Statin Use for the Primary Prevention of Cardiovascular Disease … of statins as a preventive measure for adults aged 40 to 75 years with no history of cardiovascular disease

135. Evidence-based Practice Center Systematic Review Protocol: Home Mechanical Ventilators (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/hmv-protocol.pdf
     February 02, 2018 - diseases, thoracic restrictive diseases (including thoracic cage abnormalities and morbid obesity), … , thoracic restrictive diseases, chronic obstructive pulmonary diseases (COPD), or other lung diseases … obstructive pulmonary disease,  Other lung diseases (cystic fibrosis, bronchiectasis) • Interventions …  Neuromuscular diseases  Thoracic restrictive diseases • Thoracic cage abnormalities • Morbid … , thoracic restrictive diseases, interstitial lung disease, chronic obstructive pulmonary disease

136. EvidenceNOW Publications | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/evidencenow/projects/heart-health/research-results/results/publications.html
     June 01, 2023 - Three quality measures were collected quarterly over one year: aspirin for ischemic vascular disease; … Quality of cardiovascular disease care in small urban practices. … Cardiovascular disease guideline adherence: An RCT using practice facilitation. … Cardiovascular Disease Preventive Services Among Smaller Primary Care Practices. … care practices to better identify, track, and manage early and ongoing COVID-19 cases as well as other diseases

137. 5 Tk2 P1T3-Checklist For Discussion With Local Hospitals Providers Ers Phase 1 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_P1T3-Checklist_for_Discussion_with_Local_Hospitals_Providers_ERs_Phase_1.pdf
     May 01, 2014 - reasonable to reach out also to hospital staff involved in microbiology, infection control, and infectious diseases … Number ___________________________ Email Address ______________________________ Infectious diseases … These physicians treat patients with infectious diseases and may have important clinical input … frontline clinicians (Emergency q Yes q No Department physicians, hospitalists, infectious disease

138. Best Practices Guide for COVID-19 Infection Control and Prevention in Nursing Homes (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/nursing-home/infection-control-and-prevention.pdf
     March 01, 2022 - adults.1 A thoughtful approach to infection control and prevention that follows the latest Centers for Disease … Quarantine separates and restricts the movement of people who have been exposed to a contagious disease … Isolation separates people who are sick with a contagious disease from those who are not, to prevent … Your Behavioral Health: Tips for Social Distancing, Quarantine, and Isolation during an Infectious Disease

139. PBRN Registry Search | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/ncepcr/communities/pbrn/registry/index.html
     March 25, 2024 - are pharmacists) (6) Research Interests Arthritis and other non-traumatic joint disease … muscle, bone, joint conditions)* (44) Behavioral health (60) Cancer* (42) Cardiovascular disease … research (100) Coordination of care for complex patients (88) Dementia, including Alzheimer's disease … limitations and physical disabilities* (28) Health literacy (95) Immunizations (74) Infectious diseases … including HIV/AIDS, STDs* (41) Men's health issues (13) Obesity* (125) Other health or disease

140. Health Care Simulation to Advance Safety | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/research/findings/factsheets/errors-safety/simulproj15/index.html
     August 01, 2018 - As the Ebola virus disease is amply demonstrating, health care is a high-risk industry. … Although the numbers of patients with Ebola virus disease to be admitted to U.S. hospitals is expected … Return to Contents A Global Challenge The deadly 2014–15 West African Ebola virus disease has taken … Virulent disease does not respect national borders. … Simulation as a critical resource in the response to Ebola virus disease.